NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD
Sign Up to like & getrecommendations! Published in 2018 at "Kidney International Reports"
DOI: 10.1016/j.ekir.2017.08.003
Abstract: Introduction Serum phosphate levels are insufficiently controlled in many patients with end-stage renal disease (ESRD), and novel therapeutic strategies are needed. Blocking intestinal phosphate absorption mediated by sodium-dependent phosphate co-transporter type 2b (NPT-IIb) holds promise;… read more here.
Keywords: esrd patients; serum phosphate; npt iib; iib inhibition ... See more keywords